| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.14 | 0.05 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.05 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.076 | 0.05 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.063 | 0.05 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.094 | 0.05 |